Journals / Experimental Biomedical Research / 2021 / Cilt: 4 - Sayı: 3

COVID-19 Pandemic: A comparison of adult and pediatric populations

Pages
237–243
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Multicenter studies with more numbers of patients should be performed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Couple of pneumonia cases were reported in a short period in Wuhan, China.
📊
Key Findings & Data:The cases were revealed to be associated with a different coronavirus type was named SARS-CoV-2 and the disease was identified as Covid-19.
💡
Conclusion & Impact:Multicenter studies with more numbers of patients should be performed.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:Domain Parameters

Özet

Aim: Couple of pneumonia cases were reported in a short period in Wuhan, China. The cases were revealed to be associated with a different coronavirus type was named SARS-CoV-2 and the disease was identified as Covid-19. It is known that the disease occurs in all age groups. We aimed to evaluate the differences in clinical and laboratory features between adult and pediatric patients. Method: The study is a retrospective cross-sectional study and consists of 206 patients with a definitive diagnosis of Covid-19 confirmed by a positive real-time reverse-transcriptase polymerase chain reaction (RT-PCR) testing for SARS-CoV-2. They hospitalized in health institutions connected to City Health Administrative of Bolu, Turkey between 11.03.2020 and 19.04.2020. The number of the pediatric patients (0-17 age group) was 106, that of the adult patients (18 and above age group) was 100. Data concerning the patients consisted of age, symptoms, laboratory parameters such as hemogram, biochemistry, coagulation. Results: The mean values of platelet (PLT), platocrit (PCT), percentage of monocytes (MONO %) and MONO in the “0-17” age group were found to be significantly higher than the mean values in the “18 and above” age group. The hemoglobin (HGB) mean value of the “0-17” age group was significantly lower than that of the “18 and above” age group. The mean C - reactive protein (CRP) value of the “0-17” age group (4.55; min: 1.20 – max: 11.80) was significantly lower than that of the “18 and above” age group (5.35; min 1.25- max: 19.77) with no statistically significance. In pediatric group, the most common symptoms were other symptoms like diarrhea, vomiting and joint pain whereas the adult patients had fever and cough often with statistically significant. Conclusion: Clinical findings and laboratory abnormalities in Covid-19 are less common in children. Although it seems that Covid-19 is less symptomatic in children, they are also affected by the disease. Performing RT-PCR test based on the contact history of the children may help to minimize morbidity with an early diagnosis. Multicenter studies with more numbers of patients should be performed.

🔖

Cite This Article

DEMİRKOL, M. E., KAYA, M., BALCI, M., ÖZSARI, E. (2021). COVID-19 Pandemic: A comparison of adult and pediatric populations. Experimental Biomedical Research, Cilt: 4 - Sayı: 3, 237–243. https://ajindex.com/articles/348216

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Zhu N, Zhang D, Wang W, et al. China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020
  2. 382(8):727-33. [2]World Health Organization.Novel coronavirus—China2020 (At https://www.who.int/csr/don/ 12-january2020-novel -coronavirus-china/en/). [3]Huang C, Wang Y, Li X, et al
  3. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020
  4. 395(10223):497-506. [4]Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020
  5. 395 (10223):507- 13. [5]Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020 Jun
  6. 109(6):1088-1095. [6]Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020
  7. 41(2):145– 151. [7]Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020
  8. 323(14):1335. [8]Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020
  9. 145(6):e20200702. [9]Henry BM, Lippi G, Plebani M. Laboratory abnormalities in children with novel coronavirus disease 2019. Clin Chem Lab Med. 2020
  10. 58(7):1135-38. [10]Weiss SR, Leibowitz JL. Coronavirus pathogenesis. Adv Virus Res. 2011
  11. Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med.2012
  12. 367(19):1814-20. [12]Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association. [An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19)]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020
  13. 41(2):139-144. [13]CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020
  14. 69(14):422-26. [14]Lu X, Zhang L, Du H, et al. Chinese Pediatric Novel Coronavirus Study Team. N Engl J Med. 2020
  15. 382(17):1663-65. [15]Jiehao C, Jin X, Daojiong L, et al. A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features. Clin Infect Dis. 2020
  16. 71(6):1547-51. [16]Yang P, Liu P, Li D, Zhao D. Corona Virus Disease 2019, a gr